The approval of TEPOXX in Japan marks another significant milestone in our mission to expand access to this critical ...

On Thursday, the Japan Ministry of Health, Labour and Welfare approved SIGA Technologies (NASDAQ:SIGA) antiviral treatment ...

(RTTNews) - SIGA Technologies, Inc. (SIGA), Thursday announced that its tecovirimat 200 mg capsules, traded as TEPOXX, has secured regulatory approval in Japan for the treatment of smallpox, mpox, ...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...

Siga Technologies (SIGA)’ antiviral treatment Tepoxx, has received regulatory approval in Japan for the treatment of smallpox, mpox, cowpox, as ...

Dec 10 (Reuters) - Siga Technologies' (SIGA.O), opens new tab antiviral drug did not reduce the time to lesion resolution or have an effect on pain among adults affected by the clade II strain of ...

SIGA Technologies receives Japanese approval for Tepoxx for the treatment of orthopoxviruses: New York Saturday, January 4, 2025, 12:00 Hrs [IST] SIGA Technologies, a commercial s ...

One stock to keep an eye on is Siga Technologies (SIGA). SIGA is currently sporting a Zacks Rank of #2 (Buy), as well as an A grade for Value. Value investors also frequently use the P/S ratio.